Entero Therapeutics (ENTO) announced that it has secured a $2M revolving loan agreement and subsequently appointed three new members to its ...
Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback